BBlogFlow

A plain-English guide to AI jargon - WBUR

·1h ago

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email
Photo credit : This photograph shows a figurine in front of the logo of the US artificial intelligence safety and research company Anthropic during a photo session in Paris on February 13, 2026. (Joel Saget / AFP via Getty Images)

Support WBURThis photograph shows a figurine in front of the logo of the US artificial intelligence safety and research company Anthropic during a photo session in Paris on February 13, 2026. (Joel Saget / AFP via Getty Images)It's hard to crack open a newspaper or watch the news without a new story about artificial intelligence, or AI, as we now call it. But deciphering what's being said, with the jargon expanding as quickly as the armies of rogue bots, has most of us scratching our heads. What is an 'agent'? What's a sandbox (hint, it's not real and it holds no sand)? And what about 'recursive self-improvement,' 'distillation,' or 'the singularity'? Boston Globe columnist Larry Edelman joins Here & Now's Robin Young to define some of the most common AI terms and explain their significance. His recent column in the Boston Globe is "AI making your head spin? Here's a plain English guide to the jargon. "This segment airs on October 19, 2026. Audio will be available after the broadcast. Here & Now: Editors' PicksInside AI

This article is an excerpt. To read the full content, visit the original source. WBUR

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Daimon Robotics building the infrastructure layer for tactile intelligence - The Robot Report

Vision has become central to modern robotics, but cameras alone cannot tell a robot everything it needs to know about physical contact. When handling flexible objects, inserting components, or manipulating delicate items, robots need information about forces, slippage, and contact that visual systems may miss. Daimon Robotics wants to provide the infrastructure to help robots develop that capability.

The Robot Report·

Apple Stock Holds Strong Amid Healthy iPhone Duo Preorders - Investor's Business Daily

@media screen and (max-width: 1000px){brand-hat{height:35px}:host{display:flex;flex-direction:column}}.hidden{display:none !important}.block{display:block !important}.flex{display:flex}@media screen and (min-width: 1457px){.ibd-container{width:1224px;margin:0 auto}}@media screen and (min-width: 1281px) and (max-width: 1456px){.ibd-container{padding:0 15px;width:1194px;margin:0 auto}}@media screen and (min-width: 1138px) and (max-width: 1280px){.ibd-container{padding:0 15px;width:1092px;margin:0 auto}}@media screen and (min-width: 1001px) and (max-width: 1137px){.ibd-container{padding:0 15px;max-width:100%;margin:0 auto}}@media screen and (min-width: 1001px){.desktop{display:block !important}.mobile{display:none !important}}@media screen and (max-width: 1000px){.ibd-container{padding:0 16px}.desktop{display:none !important}.mobile{display:block !important}} font-family: "IBD-Universal-Nav-OpenSans-Medium";

Investor's Business Daily·

Novel Androgen Receptor Degrader Demonstrates Antitumor Activity in Advanced Prostate Cancer - The ASCO Post

The novel androgen receptor degrader bavdegalutamide demonstrated a manageable safety profile and antitumor activity in patients with metastatic castration–resistant prostate cancer previously treated with androgen receptor pathway inhibitors, particularly those with tumors harboring specific androgen receptor mutations, according to findings from a phase I/II study reported by Gao et al in the Journal of Clinical Oncology. The open-label, phase I/II study (ClinicalTrials.gov identifier NCT03888612) enrolled 239 patients at 20 U. S. sites. Eligible patients had metastatic castration–resistant prostate cancer and had previously received at least one androgen receptor pathway inhibitor. The investigators evaluated bavdegalutamide (ARV-110), a proteolysis-targeting chimera (PROTAC) designed to promote androgen receptor degradation through recruitment of an E3 ubiquitin ligase.

The ASCO Post·

UARX Space troubleshoots anomalies on maiden OTV Flight - SpaceNews

SAN FRANCISCO –Spanish startup UARX Space is remedying anomalies identified during the maiden flight of OSSIE-D, an orbital transfer vehicle (OTV) launched Oct. 1 aboard SpaceX’s Transporter-18 mission. At least 10 PocketQubes have been deployed. “Immediately after launch, we experienced a communications blackout with our spacecraft,” Andrés Villa Granata, UARX co-founder and chief technology officer, told SpaceNews by email.

SpaceNews·